2024-12-012025-11-302025-11-30false11062635PSYCHIATRIC CONSULTATIONS LTD2026-02-2586220falseiso4217:GBPxbrli:pure110626352024-11-30110626352025-11-30110626352024-12-012025-11-30110626352023-11-30110626352024-11-30110626352023-12-012024-11-3011062635bus:SmallEntities2024-12-012025-11-3011062635bus:AuditExempt-NoAccountantsReport2024-12-012025-11-3011062635bus:AbridgedAccounts2024-12-012025-11-3011062635bus:PrivateLimitedCompanyLtd2024-12-012025-11-3011062635core:WithinOneYear2025-11-3011062635core:AfterOneYear2025-11-3011062635core:WithinOneYear2024-11-3011062635core:AfterOneYear2024-11-3011062635core:ShareCapital2025-11-3011062635core:SharePremium2025-11-3011062635core:RevaluationReserve2025-11-3011062635core:OtherReservesSubtotal2025-11-3011062635core:RetainedEarningsAccumulatedLosses2025-11-3011062635core:ShareCapital2024-11-3011062635core:SharePremium2024-11-3011062635core:RevaluationReserve2024-11-3011062635core:OtherReservesSubtotal2024-11-3011062635core:RetainedEarningsAccumulatedLosses2024-11-3011062635core:LandBuildings2025-11-3011062635core:PlantMachinery2025-11-3011062635core:Vehicles2025-11-3011062635core:FurnitureFittings2025-11-3011062635core:OfficeEquipment2025-11-3011062635core:NetGoodwill2025-11-3011062635core:IntangibleAssetsOtherThanGoodwill2025-11-3011062635core:ListedExchangeTraded2025-11-3011062635core:UnlistedNon-exchangeTraded2025-11-3011062635core:LandBuildings2024-11-3011062635core:PlantMachinery2024-11-3011062635core:Vehicles2024-11-3011062635core:FurnitureFittings2024-11-3011062635core:OfficeEquipment2024-11-3011062635core:NetGoodwill2024-11-3011062635core:IntangibleAssetsOtherThanGoodwill2024-11-3011062635core:ListedExchangeTraded2024-11-3011062635core:UnlistedNon-exchangeTraded2024-11-3011062635core:LandBuildings2024-12-012025-11-3011062635core:PlantMachinery2024-12-012025-11-3011062635core:Vehicles2024-12-012025-11-3011062635core:FurnitureFittings2024-12-012025-11-3011062635core:OfficeEquipment2024-12-012025-11-3011062635core:NetGoodwill2024-12-012025-11-3011062635core:IntangibleAssetsOtherThanGoodwill2024-12-012025-11-3011062635core:ListedExchangeTraded2024-12-012025-11-3011062635core:UnlistedNon-exchangeTraded2024-12-012025-11-3011062635core:MoreThanFiveYears2024-12-012025-11-3011062635core:Non-currentFinancialInstruments2025-11-3011062635core:Non-currentFinancialInstruments2024-11-3011062635dpl:CostSales2024-12-012025-11-3011062635dpl:DistributionCosts2024-12-012025-11-3011062635core:LandBuildings2024-12-012025-11-3011062635core:PlantMachinery2024-12-012025-11-3011062635core:Vehicles2024-12-012025-11-3011062635core:FurnitureFittings2024-12-012025-11-3011062635core:OfficeEquipment2024-12-012025-11-3011062635dpl:AdministrativeExpenses2024-12-012025-11-3011062635core:NetGoodwill2024-12-012025-11-3011062635core:IntangibleAssetsOtherThanGoodwill2024-12-012025-11-3011062635dpl:GroupUndertakings2024-12-012025-11-3011062635dpl:ParticipatingInterests2024-12-012025-11-3011062635dpl:GroupUndertakingscore:ListedExchangeTraded2024-12-012025-11-3011062635core:ListedExchangeTraded2024-12-012025-11-3011062635dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-12-012025-11-3011062635core:UnlistedNon-exchangeTraded2024-12-012025-11-3011062635dpl:CostSales2023-12-012024-11-3011062635dpl:DistributionCosts2023-12-012024-11-3011062635core:LandBuildings2023-12-012024-11-3011062635core:PlantMachinery2023-12-012024-11-3011062635core:Vehicles2023-12-012024-11-3011062635core:FurnitureFittings2023-12-012024-11-3011062635core:OfficeEquipment2023-12-012024-11-3011062635dpl:AdministrativeExpenses2023-12-012024-11-3011062635core:NetGoodwill2023-12-012024-11-3011062635core:IntangibleAssetsOtherThanGoodwill2023-12-012024-11-3011062635dpl:GroupUndertakings2023-12-012024-11-3011062635dpl:ParticipatingInterests2023-12-012024-11-3011062635dpl:GroupUndertakingscore:ListedExchangeTraded2023-12-012024-11-3011062635core:ListedExchangeTraded2023-12-012024-11-3011062635dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-12-012024-11-3011062635core:UnlistedNon-exchangeTraded2023-12-012024-11-3011062635core:NetGoodwill2025-11-3011062635core:IntangibleAssetsOtherThanGoodwill2025-11-3011062635core:LandBuildings2025-11-3011062635core:PlantMachinery2025-11-3011062635core:Vehicles2025-11-3011062635core:FurnitureFittings2025-11-3011062635core:OfficeEquipment2025-11-3011062635core:AfterOneYear2025-11-3011062635core:WithinOneYear2025-11-3011062635core:ListedExchangeTraded2025-11-3011062635core:UnlistedNon-exchangeTraded2025-11-3011062635core:ShareCapital2025-11-3011062635core:SharePremium2025-11-3011062635core:RevaluationReserve2025-11-3011062635core:OtherReservesSubtotal2025-11-3011062635core:RetainedEarningsAccumulatedLosses2025-11-3011062635core:NetGoodwill2024-11-3011062635core:IntangibleAssetsOtherThanGoodwill2024-11-3011062635core:LandBuildings2024-11-3011062635core:PlantMachinery2024-11-3011062635core:Vehicles2024-11-3011062635core:FurnitureFittings2024-11-3011062635core:OfficeEquipment2024-11-3011062635core:AfterOneYear2024-11-3011062635core:WithinOneYear2024-11-3011062635core:ListedExchangeTraded2024-11-3011062635core:UnlistedNon-exchangeTraded2024-11-3011062635core:ShareCapital2024-11-3011062635core:SharePremium2024-11-3011062635core:RevaluationReserve2024-11-3011062635core:OtherReservesSubtotal2024-11-3011062635core:RetainedEarningsAccumulatedLosses2024-11-3011062635core:NetGoodwill2023-11-3011062635core:IntangibleAssetsOtherThanGoodwill2023-11-3011062635core:LandBuildings2023-11-3011062635core:PlantMachinery2023-11-3011062635core:Vehicles2023-11-3011062635core:FurnitureFittings2023-11-3011062635core:OfficeEquipment2023-11-3011062635core:AfterOneYear2023-11-3011062635core:WithinOneYear2023-11-3011062635core:ListedExchangeTraded2023-11-3011062635core:UnlistedNon-exchangeTraded2023-11-3011062635core:ShareCapital2023-11-3011062635core:SharePremium2023-11-3011062635core:RevaluationReserve2023-11-3011062635core:OtherReservesSubtotal2023-11-3011062635core:RetainedEarningsAccumulatedLosses2023-11-3011062635core:AfterOneYear2024-12-012025-11-3011062635core:WithinOneYear2024-12-012025-11-3011062635core:Non-currentFinancialInstrumentscore:CostValuation2024-12-012025-11-3011062635core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-012025-11-3011062635core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-012025-11-3011062635core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-012025-11-3011062635core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-012025-11-3011062635core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-012025-11-3011062635core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-012025-11-3011062635core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-012025-11-3011062635core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-012025-11-3011062635core:Non-currentFinancialInstrumentscore:CostValuation2025-11-3011062635core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-11-3011062635core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-11-3011062635core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-11-3011062635core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-11-3011062635core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-11-3011062635core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-11-3011062635core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-11-3011062635core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-11-3011062635core:Non-currentFinancialInstrumentscore:CostValuation2024-11-3011062635core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-11-3011062635core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-11-3011062635core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-11-3011062635core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-11-3011062635core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-11-3011062635core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-11-3011062635core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-11-3011062635core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-11-3011062635bus:Director12024-12-012025-11-3011062635bus:Director22024-12-012025-11-30

PSYCHIATRIC CONSULTATIONS LTD

Registered Number
11062635
(England and Wales)

Unaudited Financial Statements for the Year ended
30 November 2025

PSYCHIATRIC CONSULTATIONS LTD
Company Information
for the year from 1 December 2024 to 30 November 2025

Directors

COLLINGE, Tara Louise, Dr
MCBRIDE, Mark

Company Secretary

MCBRIDE, Mark

Registered Address

Building 2a, D Site Kemble Airfield
Kemble
Cirencester
GL7 6BA

Registered Number

11062635 (England and Wales)
PSYCHIATRIC CONSULTATIONS LTD
Balance Sheet as at
30 November 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets32,7103,875
2,7103,875
Current assets
Debtors253,880151,417
Cash at bank and on hand158,763137,754
412,643289,171
Creditors amounts falling due within one year(137,874)(94,038)
Net current assets (liabilities)274,769195,133
Total assets less current liabilities277,479199,008
Net assets277,479199,008
Capital and reserves
Called up share capital101100
Profit and loss account277,378198,908
Shareholders' funds277,479199,008
The financial statements were approved and authorised for issue by the Board of Directors on 25 February 2026, and are signed on its behalf by:
COLLINGE, Tara Louise, Dr
Director
Registered Company No. 11062635
PSYCHIATRIC CONSULTATIONS LTD
Notes to the Financial Statements
for the year ended 30 November 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Reducing balance (%)
Office Equipment33
2.Average number of employees

20252024
Average number of employees during the year11
3.Tangible fixed assets

Total

£
Cost or valuation
At 01 December 2411,105
Additions183
At 30 November 2511,288
Depreciation and impairment
At 01 December 247,230
Charge for year1,348
At 30 November 258,578
Net book value
At 30 November 252,710
At 30 November 243,875